Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,610,027
-$507,928 QoQ
Shares Held
14,346
-24.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#1,526
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keystone Financial Group holds $28,513,517 across 12 Drug Manufacturers - General names. ABBV ranks #3 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,287 | $12,009,479 | |
| 2 | LLY |
ELI LILLY & Co
|
4,531 | $5,434,617 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,346 | $3,610,027 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,960 | $2,564,860 | |
| 5 | PFE |
Pfizer Inc
|
80,610 | $1,941,088 | |
| 6 | AMGN |
Amgen Inc
|
2,034 | $736,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,142 | $523,300 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,578 | $494,264 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,610,027 | 14,346 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,117,955 | 18,934 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,318,461 | 18,900 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,554,854 | 19,672 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,392,947 | 18,279 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,689,437 | 17,609 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,190,070 | 17,952 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,513,366 | 17,791 | Shares | Sole | 2025-02-19 | |
| 2024-06-30 | $3,072,437 | 17,913 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,991,538 | 16,428 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,287,822 | 14,763 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,268,395 | 15,218 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,103,808 | 15,615 | Shares | Sole | 2023-08-07 | |
| 2022-12-31 | $2,463,744 | 15,245 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,029,657 | 15,123 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,209,945 | 14,429 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,332,762 | 14,390 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,906,567 | 14,081 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,645,341 | 15,253 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,673,041 | 14,853 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,577,306 | 14,575 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,601,785 | 14,949 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,302,726 | 14,873 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,515,408 | 15,435 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,184,830 | 15,551 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||